Strategic Services Adelphi Group offers a broad suite of strategic marketing, market access, pricing and reimbursement, and real-world evidence services, presenting multiple cross-sell opportunities to pharma clients seeking end-to-end commercialization support.

Global Footprint Headquartered in Manchester with offices in Europe and the US, Adelphi serves global pharmaceutical clients, suggesting potential for multi-region contracts and partnership expansions across North America and Europe.

Data and Insights With capabilities in market intelligence, health economics outcomes research, and disease-specific programs, Adelphi can be a partner for clients needing robust evidence generation and value dossiers to support market access.

Technology & Tools Usage of analytics and web technologies such as Stata and market-facing tools indicates readiness to support data-driven studies, dashboards, and digital health communications for client programs.

Growth Signals Revenue scale ($250M-$500M) and leadership transition in the US leadership team signal ongoing growth and potential opportunities for expanded US-market services, renewals, and larger project scopes.